Peter A. Boxer

1.8k total citations
34 papers, 1.3k citations indexed

About

Peter A. Boxer is a scholar working on Cellular and Molecular Neuroscience, Molecular Biology and Organic Chemistry. According to data from OpenAlex, Peter A. Boxer has authored 34 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Cellular and Molecular Neuroscience, 15 papers in Molecular Biology and 8 papers in Organic Chemistry. Recurrent topics in Peter A. Boxer's work include Neuroscience and Neuropharmacology Research (15 papers), Ion channel regulation and function (6 papers) and Pharmacological Receptor Mechanisms and Effects (3 papers). Peter A. Boxer is often cited by papers focused on Neuroscience and Neuropharmacology Research (15 papers), Ion channel regulation and function (6 papers) and Pharmacological Receptor Mechanisms and Effects (3 papers). Peter A. Boxer collaborates with scholars based in United States, China and Denmark. Peter A. Boxer's co-authors include Michael H. Chase, Francisco R. Morales, Brian D. Ross, Oded Ben‐Yoseph, Simon J. Fung, Christopher F. Bigge, Daniel F. Ortwine, Mark G. Vartanian, Richard M. Woodward and Edward R. Whittemore and has published in prestigious journals such as The Journal of Immunology, Stroke and Journal of Neurophysiology.

In The Last Decade

Peter A. Boxer

34 papers receiving 1.2k citations

Peers

Countries citing papers authored by Peter A. Boxer

Since Specialization

Citations

This map shows the geographic impact of Peter A. Boxer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter A. Boxer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter A. Boxer more than expected).

Fields of papers citing papers by Peter A. Boxer

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Peter A. Boxer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter A. Boxer. The network helps show where Peter A. Boxer may publish in the future.

Co-authorship network of co-authors of Peter A. Boxer

This figure shows the co-authorship network connecting the top 25 collaborators of Peter A. Boxer. A scholar is included among the top collaborators of Peter A. Boxer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Peter A. Boxer. Peter A. Boxer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Nutrient plasma levels achieved during treatment that reduces noise-induced hearing loss 2011 ·Translational research ·Colleen G. Le Prell, David F. Dolan, David C. Bennett, Peter A. Boxer	30
2	Synthesis and SAR of tolylamine 5-HT6 antagonists 2009 ·Bioorganic & Medicinal Chemistry Letters ·(unknown), Michael W. Wilson, Paul D. Johnson, Shelley R. Graham, (unknown), Robin L. Roof, Peter A. Boxer, Lisa Gold, Leonard T. Meltzer, (unknown), (unknown), Jeffrey E. Campbell, Ti‐Zhi Su, Susan Hurst, Chad Stoner, Jacob B. Schwarz	17
3	Functional Differences Between Monocyte Chemotactic Protein-1 Receptor A and Monocyte Chemotactic Protein-1 Receptor B Expressed in a Jurkat T Cell 2000 ·The Journal of Immunology ·(unknown), Sheila Crean, Peter A. Boxer, (unknown), Gregory J. LaRosa, S. Hunt	50
4	Subtype-Selective N-Methyl-d-Aspartate Receptor Antagonists: Synthesis and Biological Evaluation of 1-(Heteroarylalkynyl)-4-benzylpiperidines 2000 ·Journal of Medicinal Chemistry ·Jonathan L. Wright, Tracy F. Gregory, Suzanne R. Kesten, Peter A. Boxer, Kevin A. Serpa, Leonard T. Meltzer, Lawrence D. Wise, Stephen Espitia, Christopher S. Konkoy, Edward R. Whittemore, Richard M. Woodward	95
5	Inhibitors of V‐Type ATPases, Bafilomycin A1 and Concanamycin A, Protect Against β‐Amyloid‐Mediated Effects on 3‐(4,5‐Dimethylthiazol‐2‐yl)‐2,5‐Diphenyltetrazolium Bromide (MTT) Reduction 1999 ·Journal of Neurochemistry ·Michael D. Kane, Roy D. Schwarz, (unknown), M. Desiree Watson, Mark R. Emmerling, Peter A. Boxer, Glenn K. Walker	19
6	Subtype-Selective N-Methyl-d-aspartate Receptor Antagonists: Synthesis and Biological Evaluation of 1-(Arylalkynyl)-4-benzylpiperidines 1999 ·Journal of Medicinal Chemistry ·Jon L. Wright, Tracy F. Gregory, Christopher F. Bigge, Peter A. Boxer, Kevin A. Serpa, Leonard T. Meltzer, Lawrence D. Wise, Sui Xiong Cai, Jon E. Hawkinson, Christopher S. Konkoy, Edward R. Whittemore, Richard M. Woodward, Zhang‐Lin Zhou	85
7	Discovery of subtype-selective NMDA receptor ligands: 4-Benzyl-1-piperidinylalkynylpyrroles, pyrazoles and imidazoles as NR1a/2B antagonists 1999 ·Bioorganic & Medicinal Chemistry Letters ·Jon L. Wright, Tracy F. Gregory, Peter A. Boxer, Leonard T. Meltzer, Kevin A. Serpa, Lawrence D. Wise, (unknown), Jincheng Huang, Christopher S. Konkoy, (unknown), Edward R. Whittemore, Richard M. Woodward, (unknown), Zhang‐Lin Zhou	15
8	Contribution of the ICE Family to Neurodegeneration 1998 ·Annals of the New York Academy of Sciences ·Brenda D. Shivers, Peter A. Boxer, Karen M. Keane, Nancy C. Kupina, (unknown), Gerald P. Schielke, Mark G. Vartanian, John P. Vasilakos	3
9	Emerging Therapeutic Advances for the Development of Second Generation Matrix Metalloproteinase Inhibitors 1997 ·Current Pharmaceutical Design ·Andrew D. White, Thomas Bocan, Peter A. Boxer, Janet T. Peterson, Denis J. Schrier	37
10	Noninvasive assessment of the relative roles of cerebral antioxidant enzymes by quantitation of pentose phosphate pathway activity 1996 ·Neurochemical Research ·Oded Ben‐Yoseph, Peter A. Boxer, Brian D. Ross	21
11	Assessment of the Role of the Glutathione and Pentose Phosphate Pathways in the Protection of Primary Cerebrocortical Cultures from Oxidative Stress 1996 ·Journal of Neurochemistry ·Oded Ben‐Yoseph, Peter A. Boxer, Brian D. Ross	156
12	Synthesis of 1,4,7,8,9,10-hexahydro-9-methyl-6-nitropyrido[3,4-f]-quinoxaline-2,3-dione and related quinoxalinediones: characterization of .alpha.-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (and N-methyl-D-aspartate) receptor and anticonvulsant activity 1995 ·Journal of Medicinal Chemistry ·Christopher F. Bigge, Thomas C. Malone, Peter A. Boxer, (unknown), Daniel F. Ortwine, (unknown), (unknown), (unknown), Susan A. Borosky	50
13	The voltage-sensitive Ca2+ channel (VSCC) antagonists ω-Aga-IVA and ω-CTX-MVIIC inhibit spontaneous epileptiform dischares in the rat cortical wedge 1994 ·Brain Research ·(unknown), Siegfried Wurster, Peter A. Boxer	14
14	Oxidative Stress in the Central Nervous System: Monitoring the Metabolic Response using the Pentose Phosphate Pathway 1994 ·Developmental Neuroscience ·Oded Ben‐Yoseph, Peter A. Boxer, Brian D. Ross	53
15	Substituted 2-Benzothiazolamines as Sodium Flux Inhibitors: Quantitative Structure-Activity Relationships and Anticonvulsant Activity 1994 ·Journal of Pharmaceutical Sciences ·Sheryl J. Hays, Michael J. Rice, Daniel F. Ortwine, Graham Johnson, Roy D. Schwarz, (unknown), (unknown), Mark G. Vartanian, Peter A. Boxer	96
16	N-sulfonyl derivatives of 6,7-dichloro 3,4-dihydro-3-oxo-quinoxalinecarboxylate as glycine-site NMDA and AMPA antagonists 1993 ·Bioorganic & Medicinal Chemistry Letters ·Sheryl J. Hays, Peter A. Boxer, Charles P. Taylor, Mark G. Vartanian, (unknown), Elsebet Ø. Nielsen	7
17	.beta.-Proline analogs as agonists at the strychnine-sensitive glycine receptor 1992 ·Journal of Medicinal Chemistry ·Graham Johnson, James T. Drummond, Peter A. Boxer, Robert F. Bruns	22
18	Alterations of group IA-motoneuron monosynaptic EPSPs in aged cats 1988 ·Experimental Neurology ·Peter A. Boxer, Francisco R. Morales, Michael H. Chase	20
19	Behavioral state-specific inhibitory postsynaptic potentials impinge on cat lumbar motoneurons during active sleep 1987 ·Experimental Neurology ·Francisco R. Morales, Peter A. Boxer, Michael H. Chase	43
20	Production of collagenase by mouse peritoneal macrophages in vitro characterization of sites of cleavage of tropocollagen 1976 ·Biochimica et Biophysica Acta (BBA) - General Subjects ·Peter A. Boxer, S. Joseph Leibovich	8

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact